CluenexMarsh & McLennan MRSH
Marsh & McLennan scores good on business quality (7.4 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Marsh & McLennan does
Marsh & McLennan Companies operates as a professional services firm, generating revenue through risk, strategy, and insurance brokerage services paid by corporate clients worldwide. The company is expanding its footprint through strategic acquisitions like Accel Holdings to capture additional market share in risk consulting.
- What it does best
Marsh excels at generating high returns on equity, posting an roe of 26.5% that outpaces peers like AJG at 6.7% and BRO at 9.6%. This reflects deep client integration and specialized risk expertise that rivals cannot easily replicate.
- The main risk
Debt load remains a structural pressure point, with total debt sitting at $19.6 billion against $2.7 billion in cash. If refinancing costs spike or free cash flow dips, interest obligations will consume a larger share of earnings.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin stands at 25.2% backed by efficient risk advisory operations. Profitability remains resilient as revenue scales, though debt servicing costs create a drag on net margins.
Switching costs form its primary moat, locking in corporate clients who rely on complex proprietary risk data. Its ROE sits in the top quartile of its financial services sector at the 83rd percentile.
Revenue reached $27.9 billion with a growth rate of 10.3%, supported by ongoing acquisitions like Accel Holdings. Historical summaries show steady top-line expansion from $17.2 billion in 2020.
Total debt of $19.6 billion outweighs the $2.7 billion cash pile, while interest coverage sits at 7.3x. Free cash flow reached $4.8 billion, showing strong conversion getting softer as debt climbs.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
4 sold $4.9M outside pre-planned sales.
Our sealed record on MRSH
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Marsh & McLennan scores good on the Cluenex quality check (7.4 of 10), measured against its own industry. Profitability is strong, moat strong, growth steady and financial health strong.
In the last 90 days of SEC Form 4 filings: 4 sold $4.9M outside pre-planned sales.
Oct 15, 2026, before the open.
See MRSH today
- Today's verdict on MRSH, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Marsh & McLennan (MRSH)”, https://cluenex.com/stocks/mrsh/, data as of Oct 10, 2026.